DENTSPLY SIRONA INC (XRAY) Stock Analyst Ratings
NASDAQ:XRAY • US24906P1093
14.31 USD
-0.37 (-2.52%)
At close: Mar 2, 2026
14.7 USD
+0.39 (+2.73%)
After Hours: 3/2/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 70% to XRAY. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 13.22. This target is -7.59% below the current price.
- XRAY was analyzed by 22 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about XRAY.
- In the previous month the buy percentage consensus was at a similar level.
- XRAY was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-03-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-03-02 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-27 | Baird | Maintains | Neutral -> Neutral |
| 2026-02-19 | B of A Securities | Upgrade | Neutral -> Buy |
| 2026-02-03 | UBS | Maintains | Buy -> Buy |
| 2026-01-20 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-16 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-16 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-09 | Barclays | Initiate | Underweight |
| 2025-11-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-07 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-28 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-26 | Needham | Reiterate | Hold -> Hold |
| 2025-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-07-21 | Needham | Reiterate | Hold -> Hold |
| 2025-05-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-04-30 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-13 | Mizuho | Maintains | Neutral -> Neutral |
DENTSPLY SIRONA INC / XRAY FAQ
What is the average price target for DENTSPLY SIRONA INC (XRAY) stock?
22 analysts have analysed XRAY and the average price target is 13.22 USD. This implies a price decrease of -7.59% is expected in the next year compared to the current price of 14.31.
What is the consensus rating for XRAY stock?
The consensus rating for DENTSPLY SIRONA INC (XRAY) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.